Buscato, Alberto N.

HRN: 01-36-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
CO-AMOXICLAV 625MG (TAB)
04/12/2022
04/19/2022
PO
625MG
Q8
SOFT TISSUE INJURY
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: